AUAUniversity Podcast Series: Episode No. 35

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Co-Host: Yair Lotan, MD

At the conclusion of these activities, participants will be able to:
1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients.
2. Facilitate discussions with patients and caregivers regarding of bladder cancer treatment options.

This educational series is supported by independent educational grants from:
Bristol-Myers Squibb
Genomic Health
Pfizer, Inc.
Sanofi Genzyme
UroGen Pharma